GSK Investigational Site is a clinical research site located in Birmingham, Alabama, United States 35294-0021.
Crixeo Clinical Trials Trust Score: 35/100 (FAILING). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 265 clinical trials with 12 currently active.
Therapeutic areas: Epilepsy, Epilepsy, Partial, Urinary Tract Infections.
Sponsors: GlaxoSmithKline, ViiV Healthcare, Human Genome Sciences Inc., a GSK Company.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Alabama · View every site in Birmingham
Trust Score: 35/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 35/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 265 clinical trials on record, with 12 currently active. Their work covers Epilepsy, Epilepsy, Partial, Urinary Tract Infections.
GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.